Prodotto aggiunto correttamente al carrello.

discount label
H-FRYNGLIHR-OH
Visualizzare in 3D

Biosynth logo

H-FRYNGLIHR-OH

Rif. 3D-PP44167

1mg
217,00 €
10mg
253,00 €
100mg
455,00 €
Consegna stimata in Stati Uniti, il Venerdì 27 Dicembre 2024

Informazioni sul prodotto

Nome:
H-FRYNGLIHR-OH
Sinonimi:
  • NH2-Phe-Arg-Tyr-Asn-Gly-Leu-Ile-His-Arg-OH
Descrizione:

Peptide H-FRYNGLIHR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FRYNGLIHR-OH include the following: Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A* 01) that binds an immunodominant CTL epitope from simian TM Allen , J Sidney , MF del Guercio - The Journal of , 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/160/12/6062/43834 Naturally occurring A pocket polymorphism in HLA-B* 2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides. TA Griffin, J Yuan, T Friede, S Stevanovic - (Baltimore, Md.: 1950 , 1997 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/159/10/4887/30552 Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide S Kollnberger , A Chan , MY Sun - European journal of , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200635997 A bird's eye view of NK cell receptor interactions with their MHC class I ligands PM Saunders, JP Vivian , GM O'Connor - Immunological , 2015 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/imr.12319 A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B* 2705. M Peruzzi, N Wagtmann, EO Long - The Journal of experimental , 1996 - rupress.orghttps://rupress.org/jem/article-abstract/184/4/1585/51168 Peptide sequence requirements for the recognition of HLA-B* 2705 by specific natural killer cells. M Peruzzi, KC Parker, EO Long - Journal of immunology , 1996 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/157/8/3350/110933 NK-cell receptors and recognition of MHC class I molecules M Lopez-Botet , L Moretta , J Strominger - Immunology today, 1996 - cell.comhttps://www.cell.com/imto/pdf/0167-5699(96)30009-1.pdf Antagonism of direct alloreactivity of an HLA-B27-specific CTL clone by altered peptide ligands of its natural epitope M García-Peydró , A Paradela , JP Albar - The Journal of , 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/165/10/5680/33429 Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B* 08 and HLA-B* 2705, bind peptides with sequence similarity JT Loffredo, J Sidney , AT Bean, DR Beal - The Journal of , 2009 - journals.aai.orghttps://journals.aai.org/jimmunol/article/182/12/7763/79033 The role of peptide in recognition of the Qa-1 (b) ligand by CD94/NKG2 receptors on natural killer cells HH Chuang - 2002 - search.proquest.comhttps://search.proquest.com/openview/0fbddaa14359b6704c711bb999393636/1?pq-origsite=gscholar&cbl=18750&diss=y Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B* 2705 GBE Stewart-Jones, K di Gleria - European journal of , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200425724 Structural and Functional Constraints Limit G Yu, C Brander, A Sette , BDT Kuntzen - JOURNAL OF , 2008 - drive.google.comhttps://drive.google.com/file/d/1dzvdihMCG4Mm3Tfr9QmsxBjF31oSgqs0/view Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency A Schneidewind, MA Brockman , J Sidney - Journal of , 2008 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02356-07 Functional interaction of the ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 2 with the HLA-B* 27 peptidome in human cells A Martaca­n-Esteban, P Guasp , E Barnea - Arthritis & , 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/art.39734

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP44167 H-FRYNGLIHR-OH

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".